secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ernexa Therapeutics Inc. (ERNA)
CIK:        0000748592
Form:       8-K
Filed at:   2025-02-13T23:59:59+00:00
Accession:  0001493152-25-006446
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.08
LLM model:  deepseek-v4-flash:cloud@v2

Eterna Therapeutics sets 2025 annual meeting for May 1; shareholder proposals due Feb 23
--------------------------------------------------------------------------------

- Annual meeting date: May 1, 2025; over 30 days before one-year anniversary of 2024 meeting.
- Stockholder proposals and director nominations must be received by Feb 23, 2025.
- Rule 14a-8 proposals also due Feb 23, 2025; submissions to Cambridge, MA office.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/748592/000149315225006446/0001493152-25-006446-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/748592/000149315225006446/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-006446

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer